Biweekly high-dose gemcitabine alone or in combination with capecitabine in patients with metastatic pancreatic adenocarcinoma: a randomized phase II trial.

Source:http://linkedlifedata.com/resource/pubmed/id/12488300

Download in:

View as

General Info

PMID
12488300